We would like to officially welcome Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. to the Plus Therapeutics Management Team!
“As we prepare for the future, Plus is substantially strengthening its management in key areas such as cancer biology, neuro-oncologic clinical development, and central nervous system biomarker development,” said Marc Hedrick, M.D., M.B.A. “I have worked closely with both Dr. Brenner and Dr. Blouw for some time now, and they are important new additions for our future. Their positive impact will be felt immediately.”
Press Release: https://bit.ly/PSTV_PR
https://lnkd.in/d5MhnsED
https://lnkd.in/gYhPXbe4
#GBM #Metastatic #BreastCancer #LungCancer #BrainCancer #clinicaltrials #radiotherapy #healthcare #patients #caregivers #raredisease $PSTV
Recent Comments